A study to evaluate the safety and efficacy of Vedolizumab for the treatment of inflammatory bowel disease in real world clinical practice
Phase of Trial: Phase IV
Latest Information Update: 19 Oct 2016
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease; Ulcerative colitis
- Focus Therapeutic Use
- 19 Oct 2016 Results (n=127) presented at the 24th United European Gastroenterology Week.
- 07 Oct 2016 Results (n=127) published in the Alimentary Pharmacology and Therapeutics (2016).
- 01 Apr 2016 Results (n=212) published in the Alimentary Pharmacology and Therapeutics.